天融信(002212.SZ):明泰資本被動減持期屆滿未被動減持 擬繼續被動減持不超7400.0997萬股
格隆匯12月7日丨天融信(002212.SZ)公佈,近日,公司收到持股5%以上股東明泰資本出具的書面通知,獲悉截至2022年12月7日,明泰資本第三次股份被動減持計劃的實施期限已屆滿,其所持有的7400.0997萬股公司股份(佔公司目前總股本比例6.24%)未被質權人以任何方式被動減持;因繼續存在可能因平倉導致被動減持的風險,例行披露第四次股份被動減持計劃,如採用集中競價交易方式的擬被動減持期間為2022年12月30日至2023年6月29日(根據法律法規禁止減持的期間除外)。本次擬被動減持不超7400.0997萬股(佔公司目前總股本比例6.24%)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.